Anzeige
Meldung des Tages: $95 Silber explodiert – Prince Silver vor dem nächsten Durchbruch!!

TAPESTRY PHARMA INC

Aktie
WKN:  A0JC4R ISIN:  US8760312046
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-
TAPESTRY PHARMA INC Chart

Werbung

Mehr Nachrichten kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Termine

Keine Termine bekannt.

Prognose & Kursziel

Keine aktuellen Prognosen oder Kursziele bekannt.

Stammdaten

Aktientyp Stammaktie

Community-Beiträge zu TAPESTRY PHARMA INC

  • Community-Beiträge
  • Aktuellste Threads
Avatar des Verfassers
Balu4u
Amizock oder steckt da mehr dahinter?
Avatar des Verfassers
CrashPanther
Hier habe ich mal den Artikel von Business Journal

eingefügt:

 

Tuesday, February 12, 2008

Tapestry Pharmaceuticals prepares for bankruptcy

 

Denver Business Journal

 

Tapestry Pharmaceuticals Inc. said Tuesday it intends to file for bankruptcy.

The Boulder company (NASDAQ: TPPH), which has struggled financially for years, said in a Securities and Exchange Commission it has hired a bankruptcy attorney and initiated steps to file for Chapter 11 bankruptcy protection.

Tapestry also shaved its workforce on Monday to 12 people from 34.

The company said that as of Feb. 8, it had about $100,000 of cash and cash equivalents and liabilities of about $6.5 million. The liabilities include unpaid severance costs. Tapestry said it incurred severance costs of about $3.5 million in connection with the layoffs.

Tapestry said the only positions retained are the CEO, Leonard Shaykin, the COO, the CFO, the chief medical officer, the vice president of product development and seven others.

The company also said it intends to terminate its lease, which could cost as much as $2.7 million.

Tapestry its ongoing clinical trials will be continued as much as possible to maintain the value of its clinical trial data and intellectual property. The company is working on a drug called TPI 287 as a treatment for a variety of cancers.

Tapestry said in the SEC filing that it has tried over the past year to find a way to finance its operations, including the sale of securities or the sale of the company.

Tapestry said "a number of possible buyers or investors" have decided against buying or financing the company.

"We believe that the Company has very few options now other than filing for bankruptcy and attempting to reorganize or to sell our assets in a bankruptcy proceeding," Tapestry said in the SEC filing. "In such a circumstance, holders of our common stock may receive nothing for their shares."

Good Times CP
Avatar des Verfassers
CrashPanther
Haben am 16.02.2008 Insolvenz beantragt
Aber Näheres weiß ich auch nicht.
Good Times CP
Avatar des Verfassers
CrashPanther
Leider ist die Informationspolitik von denen .....

nicht allzu berauschend, weshalb wohl auch zwei Investoren ihr Engagement reduziert haben. Unter http://www.hotstocked.com/companies/t/tapestry-pharm-TPPH-56125.html?action=showProfile findest Du mehr Infos zu der Company. Neues Symbol ist WKN: A0JC4R ISIN: US8760312046 Symbol: NA1A (NASDAQ TPPH) Hier noch die Insiderbewegungen der letzten Tage:

Activity (All Holdings)
Last 10 Insider Actions for Tapestry Pharmaceuticals Inc 
DateNameSharesStockTransaction
02/15/2008TANG CAPITAL MANAGEMENT LLC
Not Supplied
665,303TPPHOpen Market Sale
proceeds of $66,530.30
02/15/2008TANG CAPITAL MANAGEMENT LLC
Not Supplied
258,686TPPHOpen Market Sale
proceeds of $23,281.74
02/15/2008TANG CAPITAL MANAGEMENT LLC
Not Supplied
20,097TPPHOpen Market Sale
proceeds of $2,009.70
02/15/2008TANG CAPITAL MANAGEMENT LLC
Not Supplied
25,000TPPHOpen Market Sale
proceeds of $2,250.00
02/12/2008AWM INVESTMENT CO INC
Not Supplied
817,025TPPHOpen Market Sale
proceeds of $49,021.50
02/12/2008AWM INVESTMENT CO INC
Not Supplied
666,216TPPHOpen Market Sale
proceeds of $26,648.63
12/04/2007ERIC K ROWINSKY
Director
1,500TPPHNot Supplied
*** Undefined Type ***
12/04/2007ERIC K ROWINSKY
Director
1,000TPPHNot Supplied
*** Undefined Type ***
12/04/2007ERIC K ROWINSKY
Director
1,000TPPHNot Supplied
*** Undefined Type ***
12/04/2007ERIC K ROWINSKY
Director
80TPPHNot Supplied
*** Undefined Type ***

Hier noch die aktuelle Struktur :

 Company Roster
ShareholderRelationshipDirect and IndirectDate
AWM INVESTMENT CO INCNot Supplied1,918,822  02/13/2008
ANNE L BAILEYGeneral Manager & Vice PresidentN/A
BAKER BROS ADVISORS LLCNot SuppliedN/A
MARTIN M BATTSenior Vice President & Chief Operating Officer12,292  10/05/2006
MARTIN A CANNONDirectorN/A
STEPHEN K CARTERDirectorN/A
EDWARD L ERICKSONDirectorN/A
BRUCE W FIEDLERControllerN/A
GEORGE M GOULDDirectorN/A
ARTHUR HAYESDirectorN/A
KAI P LARSONVice President & General Counsel14,024  10/05/2006
GORDON H LINKChief Financial Officer & Senior Vice President21,011  10/05/2006
MATTHEW J MAJOROSController10,000  05/04/2006
MARXE AUSTIN W & GREENHOUSE DAVID MNot Supplied2,663,063  05/22/2007
ELLIOT M MAZADirectorN/A
RICHARD N PERLEDirector1,300  06/08/2007
PATRICIA A PILIADirector72,918  06/22/2006
ROBERT E POLLACKDirector110  06/08/2007
ERIC K ROWINSKYDirectorN/A
LEONARD P SHAYKINChief Executive Officer77,311  10/05/2006
TANG CAPITAL MANAGEMENT LLCNot Supplied1,143,980  02/19/2008

Good Times CP
Jetzt anmelden und diskutieren Registrieren Login
Zum Thread wechseln

Häufig gestellte Fragen zur TAPESTRY PHARMA INC Aktie und zum TAPESTRY PHARMA INC Kurs

Am 07.02.2006 gab es einen Split im Verhältnis 10:1.

Am 07.02.2006 gab es einen Split im Verhältnis 10:1.

Nein, TAPESTRY PHARMA INC zahlt keine Dividenden.